Binding of RBP-Jκ (CSL) protein to the promoter of the Kaposi's sarcoma-associated herpesvirus ORF47 (gL) gene is a critical but not sufficient determinant of transactivation by ORF50 protein

Virology

Volumn 398, Issue 1, 2010, Pages 38-48

  Chang, Pey Jium ^a,b   Boonsiri, Joseph ^c   Wang, Shih Shan ^a,b   Chen, Li Yu ^a,b   Miller, George ^c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN L; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; PROTEIN ORF47; PROTEIN ORF50; UNCLASSIFIED DRUG; VIRUS DNA; IMMEDIATE EARLY PROTEIN; RBPJ PROTEIN, HUMAN; RTA PROTEIN, HUMAN HERPESVIRUS 8; TRANSACTIVATOR PROTEIN;

5' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA FLANKING REGION; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; TRANSACTIVATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; TRANSCRIPTION INITIATION; TUMOR CELL LINE; VIRUS REPLICATION;

HUMAN HERPESVIRUS 8;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 8, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; PROTEIN BINDING; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION; VIRUS REPLICATION;

EID: 75849147654     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.11.022     Document Type: Article

References (47)

1. Ashburn C.V., and Gray W.L. Expression of the simian varicella virus glycoprotein L and H. Arch. Virol. 147 2 (2002) 335-348
2. Boshoff C., Schulz T.F., Kennedy M.M., Graham A.K., Fisher C., Thomas A., McGee J.O., Weiss R.A., and O'Leary J.J. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat. Med. 1 12 (1995) 1274-1278
3. Carroll K.D., Bu W., Palmeri D., Spadavecchia S., Lynch S.J., Marras S.A., Tyagi S., and Lukac D.M. Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway. J. Virol. 80 19 (2006) 9697-9709
4. Cesarman E., Chang Y., Moore P.S., Said J.W., and Knowles D.M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332 18 (1995) 1186-1191
5. Chang P.J., and Miller G. Autoregulation of DNA binding and protein stability of Kaposi's sarcoma-associated herpesvirus ORF50 protein. J. Virol. 78 19 (2004) 10657-10673
6. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., and Moore P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266 5192 (1994) 1865-1869
7. Chang P.J., Shedd D., Gradoville L., Cho M.S., Chen L.W., Chang J., and Miller G. Open reading frame 50 protein of Kaposi's sarcoma-associated herpesvirus directly activates the viral PAN and K12 genes by binding to related response elements. J. Virol. 76 7 (2002) 3168-3178
8. Chang P.J., Shedd D., and Miller G. Two subclasses of Kaposi's sarcoma-associated herpesvirus lytic cycle promoters distinguished by open reading frame 50 mutant proteins that are deficient in binding to DNA. J. Virol. 79 14 (2005) 8750-8763
9. Chang P.J., Shedd D., and Miller G. A mobile functional region of Kaposi's sarcoma-associated herpesvirus ORF50 protein independently regulates DNA binding and protein abundance. J. Virol. 82 19 (2008) 9700-9716
10. Chen J., Ueda K., Sakakibara S., Okuno T., and Yamanishi K. Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene. J. Virol. 74 18 (2000) 8623-8634
11. Damania B., Jeong J.H., Bowser B.S., DeWire S.M., Staudt M.R., and Dittmer D.P. Comparison of the Rta/Orf50 transactivator proteins of gamma-2-herpesviruses. J. Virol. 78 10 (2004) 5491-5499
12. Dean H.J., and Cheung A.K. A 3′ coterminal gene cluster in pseudorabies virus contains herpes simplex virus UL1, UL2, and UL3 gene homologs and a unique UL3.5 open reading frame. J. Virol. 67 10 (1993) 5955-5961
13. Deng H., Song M.J., Chu J.T., and Sun R. Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J. Virol. 76 16 (2002) 8252-8264
14. Deng H., Young A., and Sun R. Auto-activation of the rta gene of human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus. J. Gen. Virol. 81 Pt 12 (2000) 3043-3048
15. Gradoville L., Gerlach J., Grogan E., Shedd D., Nikiforow S., Metroka C., and Miller G. Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line. J. Virol. 74 13 (2000) 6207-6212
16. Haque M., Chen J., Ueda K., Mori Y., Nakano K., Hirata Y., Kanamori S., Uchiyama Y., Inagi R., Okuno T., and Yamanishi K. Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus. J. Virol. 74 6 (2000) 2867-2875
17. Jeong J., Papin J., and Dittmer D. Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters. J. Virol. 75 4 (2001) 1798-1807
18. Kato H., Taniguchi Y., Kurooka H., Minoguchi S., Sakai T., Nomura-Okazaki S., Tamura K., and Honjo T. Involvement of RBP-J in biological functions of mouse Notch1 and its derivatives. Development 124 20 (1997) 4133-4141
19. Lai E.C. Keeping a good pathway down: transcriptional repression of Notch pathway target genes by CSL proteins. EMBO Rep. 3 9 (2002) 840-845
20. Liang Y., and Ganem D. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling. Proc. Natl. Acad. Sci. U.S.A. 100 14 (2003) 8490-8495
21. Liang Y., and Ganem D. RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA. J. Virol. 78 13 (2004) 6818-6826
22. Liang Y., Chang J., Lynch S.J., Lukac D.M., and Ganem D. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev. 16 15 (2002) 1977-1989
23. Liao W., Tang Y., Kuo Y.L., Liu B.Y., Xu C.J., and Giam C.Z. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 transcriptional activator Rta is an oligomeric DNA-binding protein that interacts with tandem arrays of phased A/T-trinucleotide motifs. J. Virol. 77 17 (2003) 9399-9411
24. Liu Y., Cao Y., Liang D., Gao Y., Xia T., Robertson E.S., and Lan K. Kaposi's sarcoma-associated herpesvirus RTA activates the processivity factor ORF59 through interaction with RBP-Jkappa and a cis-acting RTA responsive element. Virology 380 2 (2008) 264-275
25. Lukac D.M., Renne R., Kirshner J.R., and Ganem D. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252 2 (1998) 304-312
26. Lukac D.M., Kirshner J.R., and Ganem D. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J. Virol. 73 11 (1999) 9348-9361
27. Lukac D.M., Garibyan L., Kirshner J.R., Palmeri D., and Ganem D. DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters. J. Virol. 75 15 (2001) 6786-6799
28. Miller G., Heston L., Grogan E., Gradoville L., Rigsby M., Sun R., Shedd D., Kushnaryov V.M., Grossberg S., and Chang Y. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J. Virol. 71 1 (1997) 314-324
29. Papugani A., Coleman T., Jones C., and Zhang L. The interaction between KSHV RTA and cellular RBP-Jkappa and their subsequent DNA binding are not sufficient for activation of RBP-Jkappa. Virus Res. 131 1 (2008) 1-7
30. Rajcani J., Andrea V., and Ingeborg R. Peculiarities of herpes simplex virus (HSV) transcription: an overview. Virus Genes 28 3 (2004) 293-310
31. Renne R., Zhong W., Herndier B., McGrath M., Abbey N., Kedes D., and Ganem D. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2 3 (1996) 342-346
32. Russo J.J., Bohenzky R.A., Chien M.C., Chen J., Yan M., Maddalena D., Parry J.P., Peruzzi D., Edelman I.S., Chang Y., and Moore P.S. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. U.S.A. 93 25 (1996) 14862-14867
33. Serio T.R., Kolman J.L., and Miller G. Late gene expression from the Epstein-Barr virus BcLF1 and BFRF3 promoters does not require DNA replication in cis. J. Virol. 71 11 (1997) 8726-8734
34. Singh J., and Wagner E.K. Transcriptional analysis of the herpes simplex virus type 1 region containing the TRL/UL junction. Virology 196 1 (1993) 220-231
35. Song M.J., Brown H.J., Wu T.T., and Sun R. Transcription activation of polyadenylated nuclear RNA by rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus. J. Virol. 75 7 (2001) 3129-3140
36. Song M.J., Li X., Brown H.J., and Sun R. Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol. 76 10 (2002) 5000-5013
37. Song M.J., Deng H., and Sun R. Comparative study of regulation of RTA-responsive genes in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol. 77 17 (2003) 9451-9462
38. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., d'Agay M.F., Clauvel J.P., Raphael M., Degos L., et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86 4 (1995) 1276-1280
39. Sun R., Lin S.F., Gradoville L., Yuan Y., Zhu F., and Miller G. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. U.S.A. 95 18 (1998) 10866-10871
40. Sun R., Lin S.F., Staskus K., Gradoville L., Grogan E., Haase A., and Miller G. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J. Virol. 73 3 (1999) 2232-2242
41. Tun T., Hamaguchi Y., Matsunami N., Furukawa T., Honjo T., and Kawaichi M. Recognition sequence of a highly conserved DNA binding protein RBP-J kappa. Nucleic Acids Res. 22 6 (1994) 965-971
42. Ueda K., Ishikawa K., Nishimura K., Sakakibara S., Do E., and Yamanishi K. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) replication and transcription factor activates the K9 (vIRF) gene through two distinct cis elements by a non-DNA-binding mechanism. J. Virol. 76 23 (2002) 12044-12054
43. Wang Y., and Yuan Y. Essential role of RBP-Jkappa in activation of the K8 delayed-early promoter of Kaposi's sarcoma-associated herpesvirus by ORF50/RTA. Virology 359 1 (2007) 19-27
44. Wang S., Liu S., Wu M., Geng Y., and Wood C. Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 ORF50 gene product contains a potent C-terminal activation domain which activates gene expression via a specific target sequence. Arch. Virol. 146 7 (2001) 1415-1426
45. Zhang L., Chiu J., and Lin J.C. Activation of human herpesvirus 8 (HHV-8) thymidine kinase (TK) TATAA-less promoter by HHV-8 ORF50 gene product is SP1 dependent. DNA Cell Biol. 17 9 (1998) 735-742
46. Zhu F.X., Cusano T., and Yuan Y. Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus. J. Virol. 73 7 (1999) 5556-5567
47. Ziegelbauer J., Grundhoff A., and Ganem D. Exploring the DNA binding interactions of the Kaposi's sarcoma-associated herpesvirus lytic switch protein by selective amplification of bound sequences in vitro. J. Virol. 80 6 (2006) 2958-2967